RxDoctor Payments Data

Irada Ibrahim-Zada, MD

Surgical Oncology · Lexington, KYNPI 1265842991

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Stryker at 52.4% of the total. That places this record below the midpoint for surgical oncology clinicians in KY, where the typical reported total is $2,984.

$2,172in general payments, 2019–2025

Across 20 payments — averaging $108.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Elucent Medical$310
  • E.r. Squibb & Sons, L.L.C.$241
  • Solventum Corporation$230
  • Tempus AI, Inc$100
  • AstraZeneca$68
  • plus $84 from 2 others

What the payments were for

  • Travel & lodging$84039%
  • Food & beverage$1,26358%
  • Education$683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,172 in reported general payments places this provider in the 45th percentile of 29 surgical oncology providers in Kentucky.

See all surgical oncology providers in Kentucky

Medicare billing

Part B allowed, 2024
$93,593
Medicare patients
116
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →